BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21377305)

  • 41. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
    J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions.
    Taouli B; Sandberg A; Stemmer A; Parikh T; Wong S; Xu J; Lee VS
    J Magn Reson Imaging; 2009 Sep; 30(3):561-8. PubMed ID: 19711402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of small intrahepatic metastases of hepatocellular carcinomas using diffusion-weighted imaging: comparison with conventional dynamic MRI.
    Yu JS; Chung JJ; Kim JH; Cho ES; Kim DJ; Ahn JH; Kim KW
    Magn Reson Imaging; 2011 Sep; 29(7):985-92. PubMed ID: 21616624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The value of diffusion-weighted imaging in characterizing focal liver masses.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Aisen AM
    Acad Radiol; 2009 Oct; 16(10):1208-14. PubMed ID: 19608435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the accuracy of diffusion-weighted imaging versus dynamic contrast enhancement magnetic resonance imaging in characterizing focal liver lesions.
    Tappouni R; ElKady RM; Sarwani N; Dykes T
    J Comput Assist Tomogr; 2013; 37(6):995-1001. PubMed ID: 24270124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diffusion-weighted MRI and liver metastases.
    Chandarana H; Taouli B
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):451-64, x. PubMed ID: 21094449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Confident non-invasive diagnosis of pseudolesions of the liver using diffusion-weighted imaging at 3T MRI.
    Fruehwald-Pallamar J; Bastati-Huber N; Fakhrai N; Jantsch M; Puchner S; Herneth AM; Ba-Ssalamah A
    Eur J Radiol; 2012 Jun; 81(6):1353-9. PubMed ID: 21507591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable?
    Kinner S; Umutlu L; Blex S; Maderwald S; Antoch G; Ertle J; Gerken G; Lauenstein TC
    Eur J Radiol; 2012 Apr; 81(4):e625-8. PubMed ID: 22297185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI.
    Schelhorn J; Best J; Reinboldt MP; Dechêne A; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Magn Reson Imaging; 2015 Sep; 42(3):818-27. PubMed ID: 25515676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diffusion-weighted magnetic resonance imaging of the liver using tracking only navigator echo: feasibility study.
    Takahara T; Kwee TC; Van Leeuwen MS; Ogino T; Horie T; Van Cauteren M; Herigault G; Imai Y; Mali WP; Luijten PR
    Invest Radiol; 2010 Feb; 45(2):57-63. PubMed ID: 20057318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion.
    Takeuchi M; Matsuzaki K; Nishitani H
    Acta Radiol; 2009 Oct; 50(8):947-53. PubMed ID: 19724949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
    Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
    J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of lymph node metastases: comparison of gadofluorine M-enhanced MRI and diffusion-weighted MRI in a rabbit VX2 rectal cancer model.
    Kim SH; Lee JM; Moon SK; Chung YE; Paik JH; Choi SH; Kim MU; Han JK; Choi BI
    J Magn Reson Imaging; 2012 May; 35(5):1179-86. PubMed ID: 22247081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic performance of diffusion-weighted MRI in the detection of nonpalpable undescended testes: comparison with conventional MRI and surgical findings.
    Kantarci M; Doganay S; Yalcin A; Aksoy Y; Yilmaz-Cankaya B; Salman B
    AJR Am J Roentgenol; 2010 Oct; 195(4):W268-73. PubMed ID: 20858788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
    Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
    Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffusion-weighted magnetic resonance imaging combined with T2-weighted images in the detection of small breast cancer: a single-center multi-observer study.
    Wu LM; Chen J; Hu J; Gu HY; Xu JR; Hua J
    Acta Radiol; 2014 Feb; 55(1):24-31. PubMed ID: 23878358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.